Recalls / Active ingredient / Labetalol Hydrochloride
Labetalol Hydrochloride
4 FDA drug recalls involving the active ingredient “Labetalol Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-20 | Class II | Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Un | Pfizer Inc. |
| 2022-04-13 | Class II | Labetalol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, MFG: Par Pharma, NDC 49884-122-01 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2018-02-20 | Class II | Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) | Hospira Inc. A Pfizer Company |
| 2014-05-16 | Class II | Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass | Hospira Inc. |